Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Matured hop bitter acids for cognitive decline in Parkinson's disease
jRCTs031190162Completed
- Sponsor
- Kyowa Kirin
- Start
- Jan 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Parkinson's disease (PD) comparing Matured hop bitter acids with Placebo (2 arms). Primary endpoints: Cognitive function (MoCA-J), Cognitive function (Stroop test) and 2 more. Started Jan 2020; status: completed.
02
Drugs
matured hop bitter acids
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on jRCTs031190162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031190162.